Filipiny - angielski - FDA (Food And Drug Administration)

surechoice pharma phils., inc. - ascorbic acid , zinc - capsule - 500mg (equivalent to 562.42 mg sodium ascorbate)/10 mg (equivalent to 27.50 mg zinc sulfate monohydrate)

Filipiny - angielski - FDA (Food And Drug Administration)

surechoice pharma phils., inc. - retinol (as palmitate) - softgel capsule - 200,000 iu

Filipiny - angielski - FDA (Food And Drug Administration)

am-europharma corp; distributor: surechoice pharma phils, inc. - retinol palmitate - softgel capsule - 200,000 iu

Filipiny - angielski - FDA (Food And Drug Administration)

surechoice pharma phils., inc. - ferrous sulfate , folic acid ,vitamin b complex - capsule - [see reverse for formulation]

Filipiny - angielski - FDA (Food And Drug Administration)

surechoice pharma phils., inc. - salbutamol (as sulfate) - syrup - 2mg/ 5ml

Filipiny - angielski - FDA (Food And Drug Administration)

surechoice pharma phils., inc. - ascorbic acid - capsule - 500mg (equi. to 568.18mg of sodium ascorbate)

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

teva women's health, inc. - bethanechol chloride (unii: h4qbz2lo84) (bethanechol - unii:004f72p8f4) - bethanechol chloride 5 mg - bethanechol chloride tablets usp are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. hypersensitivity to bethanechol chloride, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia

Kanada - angielski - Health Canada

novartis pharmaceuticals canada inc - erenumab - solution - 70mg - erenumab 70mg - calcitonin-gene-related peptide (cgrp) antagonists

Kanada - angielski - Health Canada

novartis pharmaceuticals canada inc - erenumab - solution - 70mg - erenumab 70mg - calcitonin-gene-related peptide (cgrp) antagonists

Kanada - angielski - Health Canada

novartis pharmaceuticals canada inc - erenumab - solution - 140mg - erenumab 140mg - calcitonin-gene-related peptide (cgrp) antagonists